1 Supply Summary

• 1.1 Genome Engineering Editing Introduction
• 1.2 World Genome Engineering Editing Market Size & Forecast (2021 & 2025 & 2032)
• 1.3 World Genome Engineering Editing Total Market by Region (by Headquarter Location)
  • 1.3.1 World Genome Engineering Editing Market Size by Region (2021-2032), (by Headquarter Location)
  • 1.3.2 United States Based Company Genome Engineering Editing Revenue (2021-2032)
  • 1.3.3 China Based Company Genome Engineering Editing Revenue (2021-2032)
  • 1.3.4 Europe Based Company Genome Engineering Editing Revenue (2021-2032)
  • 1.3.5 Japan Based Company Genome Engineering Editing Revenue (2021-2032)
  • 1.3.6 South Korea Based Company Genome Engineering Editing Revenue (2021-2032)
  • 1.3.7 ASEAN Based Company Genome Engineering Editing Revenue (2021-2032)
  • 1.3.8 India Based Company Genome Engineering Editing Revenue (2021-2032)
• 1.4 Market Drivers, Restraints and Trends
  • 1.4.1 Genome Engineering Editing Market Drivers
  • 1.4.2 Factors Affecting Demand
  • 1.4.3 Major Market Trends

2 Demand Summary

• 2.1 World Genome Engineering Editing Consumption Value (2021-2032)
• 2.2 World Genome Engineering Editing Consumption Value by Region
  • 2.2.1 World Genome Engineering Editing Consumption Value by Region (2021-2026)
  • 2.2.2 World Genome Engineering Editing Consumption Value Forecast by Region (2027-2032)
• 2.3 United States Genome Engineering Editing Consumption Value (2021-2032)
• 2.4 China Genome Engineering Editing Consumption Value (2021-2032)
• 2.5 Europe Genome Engineering Editing Consumption Value (2021-2032)
• 2.6 Japan Genome Engineering Editing Consumption Value (2021-2032)
• 2.7 South Korea Genome Engineering Editing Consumption Value (2021-2032)
• 2.8 ASEAN Genome Engineering Editing Consumption Value (2021-2032)
• 2.9 India Genome Engineering Editing Consumption Value (2021-2032)

3 World Genome Engineering Editing Companies Competitive Analysis

• 3.1 World Genome Engineering Editing Revenue by Player (2021-2026)
• 3.2 Industry Rank and Concentration Rate (CR)
  • 3.2.1 Global Genome Engineering Editing Industry Rank of Major Players
  • 3.2.2 Global Concentration Ratios (CR4) for Genome Engineering Editing in 2025
  • 3.2.3 Global Concentration Ratios (CR8) for Genome Engineering Editing in 2025
• 3.3 Genome Engineering Editing Company Evaluation Quadrant
• 3.4 Genome Engineering Editing Market: Overall Company Footprint Analysis
  • 3.4.1 Genome Engineering Editing Market: Region Footprint
  • 3.4.2 Genome Engineering Editing Market: Company Product Type Footprint
  • 3.4.3 Genome Engineering Editing Market: Company Product Application Footprint
• 3.5 Competitive Environment
  • 3.5.1 Historical Structure of the Industry
  • 3.5.2 Barriers of Market Entry
  • 3.5.3 Factors of Competition
• 3.6 Mergers & Acquisitions Activity

4 United States VS China VS Rest of World (by Headquarter Location)

• 4.1 United States VS China: Genome Engineering Editing Revenue Comparison (by Headquarter Location)
  • 4.1.1 United States VS China: Genome Engineering Editing Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
  • 4.1.2 United States VS China: Genome Engineering Editing Revenue Market Share Comparison (2021 & 2025 & 2032)
• 4.2 United States Based Companies VS China Based Companies: Genome Engineering Editing Consumption Value Comparison
  • 4.2.1 United States VS China: Genome Engineering Editing Consumption Value Comparison (2021 & 2025 & 2032)
  • 4.2.2 United States VS China: Genome Engineering Editing Consumption Value Market Share Comparison (2021 & 2025 & 2032)
• 4.3 United States Based Genome Engineering Editing Companies and Market Share, 2021-2026
  • 4.3.1 United States Based Genome Engineering Editing Companies, Headquarters (States, Country)
  • 4.3.2 United States Based Companies Genome Engineering Editing Revenue, (2021-2026)
• 4.4 China Based Companies Genome Engineering Editing Revenue and Market Share, 2021-2026
  • 4.4.1 China Based Genome Engineering Editing Companies, Company Headquarters (Province, Country)
  • 4.4.2 China Based Companies Genome Engineering Editing Revenue, (2021-2026)
• 4.5 Rest of World Based Genome Engineering Editing Companies and Market Share, 2021-2026
  • 4.5.1 Rest of World Based Genome Engineering Editing Companies, Headquarters (Province, Country)
  • 4.5.2 Rest of World Based Companies Genome Engineering Editing Revenue (2021-2026)

5 Market Analysis by Type

• 5.1 World Genome Engineering Editing Market Size Overview by Type: 2021 VS 2025 VS 2032
• 5.2 Segment Introduction by Type
  • 5.2.1 CRISPR RNP
  • 5.2.2 CRISPR mRNA
  • 5.2.3 CRISPR Virus Delivery
  • 5.2.4 Others
• 5.3 Market Segment by Type
  • 5.3.1 World Genome Engineering Editing Market Size by Type (2021-2026)
  • 5.3.2 World Genome Engineering Editing Market Size by Type (2027-2032)
  • 5.3.3 World Genome Engineering Editing Market Size Market Share by Type (2027-2032)

6 Market Analysis by Application

• 6.1 World Genome Engineering Editing Market Size Overview by Application: 2021 VS 2025 VS 2032
• 6.2 Segment Introduction by Application
  • 6.2.1 RUO
  • 6.2.2 GMP
• 6.3 Market Segment by Application
  • 6.3.1 World Genome Engineering Editing Market Size by Application (2021-2026)
  • 6.3.2 World Genome Engineering Editing Market Size by Application (2027-2032)
  • 6.3.3 World Genome Engineering Editing Market Size Market Share by Application (2021-2032)

7 Company Profiles

• 7.1 Thermo Fisher Scientific
  • 7.1.1 Thermo Fisher Scientific Details
  • 7.1.2 Thermo Fisher Scientific Major Business
  • 7.1.3 Thermo Fisher Scientific Genome Engineering Editing Product and Services
  • 7.1.4 Thermo Fisher Scientific Genome Engineering Editing Revenue, Gross Margin and Market Share (2021-2026)
  • 7.1.5 Thermo Fisher Scientific Recent Developments/Updates
  • 7.1.6 Thermo Fisher Scientific Competitive Strengths & Weaknesses
• 7.2 SIGMA ALDRICH
  • 7.2.1 SIGMA ALDRICH Details
  • 7.2.2 SIGMA ALDRICH Major Business
  • 7.2.3 SIGMA ALDRICH Genome Engineering Editing Product and Services
  • 7.2.4 SIGMA ALDRICH Genome Engineering Editing Revenue, Gross Margin and Market Share (2021-2026)
  • 7.2.5 SIGMA ALDRICH Recent Developments/Updates
  • 7.2.6 SIGMA ALDRICH Competitive Strengths & Weaknesses
• 7.3 Dharmacon（Horizo​​n Discovery）
  • 7.3.1 Dharmacon（Horizo​​n Discovery） Details
  • 7.3.2 Dharmacon（Horizo​​n Discovery） Major Business
  • 7.3.3 Dharmacon（Horizo​​n Discovery） Genome Engineering Editing Product and Services
  • 7.3.4 Dharmacon（Horizo​​n Discovery） Genome Engineering Editing Revenue, Gross Margin and Market Share (2021-2026)
  • 7.3.5 Dharmacon（Horizo​​n Discovery） Recent Developments/Updates
  • 7.3.6 Dharmacon（Horizo​​n Discovery） Competitive Strengths & Weaknesses
• 7.4 Cellectics
  • 7.4.1 Cellectics Details
  • 7.4.2 Cellectics Major Business
  • 7.4.3 Cellectics Genome Engineering Editing Product and Services
  • 7.4.4 Cellectics Genome Engineering Editing Revenue, Gross Margin and Market Share (2021-2026)
  • 7.4.5 Cellectics Recent Developments/Updates
  • 7.4.6 Cellectics Competitive Strengths & Weaknesses
• 7.5 CRISPR Therapeutics
  • 7.5.1 CRISPR Therapeutics Details
  • 7.5.2 CRISPR Therapeutics Major Business
  • 7.5.3 CRISPR Therapeutics Genome Engineering Editing Product and Services
  • 7.5.4 CRISPR Therapeutics Genome Engineering Editing Revenue, Gross Margin and Market Share (2021-2026)
  • 7.5.5 CRISPR Therapeutics Recent Developments/Updates
  • 7.5.6 CRISPR Therapeutics Competitive Strengths & Weaknesses
• 7.6 AstraZeneca
  • 7.6.1 AstraZeneca Details
  • 7.6.2 AstraZeneca Major Business
  • 7.6.3 AstraZeneca Genome Engineering Editing Product and Services
  • 7.6.4 AstraZeneca Genome Engineering Editing Revenue, Gross Margin and Market Share (2021-2026)
  • 7.6.5 AstraZeneca Recent Developments/Updates
  • 7.6.6 AstraZeneca Competitive Strengths & Weaknesses
• 7.7 Bio Rad
  • 7.7.1 Bio Rad Details
  • 7.7.2 Bio Rad Major Business
  • 7.7.3 Bio Rad Genome Engineering Editing Product and Services
  • 7.7.4 Bio Rad Genome Engineering Editing Revenue, Gross Margin and Market Share (2021-2026)
  • 7.7.5 Bio Rad Recent Developments/Updates
  • 7.7.6 Bio Rad Competitive Strengths & Weaknesses
• 7.8 Allele Biotech
  • 7.8.1 Allele Biotech Details
  • 7.8.2 Allele Biotech Major Business
  • 7.8.3 Allele Biotech Genome Engineering Editing Product and Services
  • 7.8.4 Allele Biotech Genome Engineering Editing Revenue, Gross Margin and Market Share (2021-2026)
  • 7.8.5 Allele Biotech Recent Developments/Updates
  • 7.8.6 Allele Biotech Competitive Strengths & Weaknesses
• 7.9 Recombinetics
  • 7.9.1 Recombinetics Details
  • 7.9.2 Recombinetics Major Business
  • 7.9.3 Recombinetics Genome Engineering Editing Product and Services
  • 7.9.4 Recombinetics Genome Engineering Editing Revenue, Gross Margin and Market Share (2021-2026)
  • 7.9.5 Recombinetics Recent Developments/Updates
  • 7.9.6 Recombinetics Competitive Strengths & Weaknesses
• 7.10 Lonza
  • 7.10.1 Lonza Details
  • 7.10.2 Lonza Major Business
  • 7.10.3 Lonza Genome Engineering Editing Product and Services
  • 7.10.4 Lonza Genome Engineering Editing Revenue, Gross Margin and Market Share (2021-2026)
  • 7.10.5 Lonza Recent Developments/Updates
  • 7.10.6 Lonza Competitive Strengths & Weaknesses
• 7.11 Illumina
  • 7.11.1 Illumina Details
  • 7.11.2 Illumina Major Business
  • 7.11.3 Illumina Genome Engineering Editing Product and Services
  • 7.11.4 Illumina Genome Engineering Editing Revenue, Gross Margin and Market Share (2021-2026)
  • 7.11.5 Illumina Recent Developments/Updates
  • 7.11.6 Illumina Competitive Strengths & Weaknesses
• 7.12 Editas Medicine
  • 7.12.1 Editas Medicine Details
  • 7.12.2 Editas Medicine Major Business
  • 7.12.3 Editas Medicine Genome Engineering Editing Product and Services
  • 7.12.4 Editas Medicine Genome Engineering Editing Revenue, Gross Margin and Market Share (2021-2026)
  • 7.12.5 Editas Medicine Recent Developments/Updates
  • 7.12.6 Editas Medicine Competitive Strengths & Weaknesses
• 7.13 Agilent Technologies
  • 7.13.1 Agilent Technologies Details
  • 7.13.2 Agilent Technologies Major Business
  • 7.13.3 Agilent Technologies Genome Engineering Editing Product and Services
  • 7.13.4 Agilent Technologies Genome Engineering Editing Revenue, Gross Margin and Market Share (2021-2026)
  • 7.13.5 Agilent Technologies Recent Developments/Updates
  • 7.13.6 Agilent Technologies Competitive Strengths & Weaknesses
• 7.14 QIAGEN NV
  • 7.14.1 QIAGEN NV Details
  • 7.14.2 QIAGEN NV Major Business
  • 7.14.3 QIAGEN NV Genome Engineering Editing Product and Services
  • 7.14.4 QIAGEN NV Genome Engineering Editing Revenue, Gross Margin and Market Share (2021-2026)
  • 7.14.5 QIAGEN NV Recent Developments/Updates
  • 7.14.6 QIAGEN NV Competitive Strengths & Weaknesses

8 Industry Chain Analysis

• 8.1 Genome Engineering Editing Industry Chain
• 8.2 Genome Engineering Editing Upstream Analysis
• 8.3 Genome Engineering Editing Midstream Analysis
• 8.4 Genome Engineering Editing Downstream Analysis

9 Research Findings and Conclusion

10 Appendix

• 10.1 Methodology
• 10.2 Research Process and Data Source

The global Genome Engineering Editing market size is expected to reach $ 31660 million by 2032, rising at a market growth of 18.0% CAGR during the forecast period (2026-2032).
Genome Engineering Editing is a modern molecular biology technology that involves targeted modifications to the genome of an organism to change the sequence of a target gene or regulate its expression. This technology is largely based on genome editing tools such as CRISPR-Cas9, which allows scientists to precisely add, delete or replace an organism's genes.
Global key players of Genome Engineering Editing include Thermo Fisher Scientific, AstraZeneca, SIGMA ALDRICH, Agilent Technologies, Illumina, etc. The top five players hold a share over 52%. North America is the largest market, and has a share about 37%, followed by Asia-Pacific and Europe with share 25% and 18%, separately. In terms of product type, CRISPR RNP is the largest segment, occupied for a share of 39%. In terms of application, GMP has a share about 70 percent.
This report studies the global Genome Engineering Editing demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Genome Engineering Editing, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Genome Engineering Editing that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Genome Engineering Editing total market, 2021-2032, (USD Million)
Global Genome Engineering Editing total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Genome Engineering Editing total market, key domestic companies, and share, (USD Million)
Global Genome Engineering Editing revenue by player, revenue and market share 2021-2026, (USD Million)
Global Genome Engineering Editing total market by Type, CAGR, 2021-2032, (USD Million)
Global Genome Engineering Editing total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Genome Engineering Editing market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Thermo Fisher Scientific, SIGMA ALDRICH, Dharmacon（Horizo​​n Discovery）, Cellectics, CRISPR Therapeutics, AstraZeneca, Bio Rad, Allele Biotech, Recombinetics, Lonza, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Genome Engineering Editing market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Genome Engineering Editing Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World
Global Genome Engineering Editing Market, Segmentation by Type:
CRISPR RNP
CRISPR mRNA
CRISPR Virus Delivery
Others
Global Genome Engineering Editing Market, Segmentation by Application:
RUO
GMP
Companies Profiled:
Thermo Fisher Scientific
SIGMA ALDRICH
Dharmacon（Horizo​​n Discovery）
Cellectics
CRISPR Therapeutics
AstraZeneca
Bio Rad
Allele Biotech
Recombinetics
Lonza
Illumina
Editas Medicine
Agilent Technologies
QIAGEN NV
Key Questions Answered
1. How big is the global Genome Engineering Editing market?
2. What is the demand of the global Genome Engineering Editing market?
3. What is the year over year growth of the global Genome Engineering Editing market?
4. What is the total value of the global Genome Engineering Editing market?
5. Who are the Major Players in the global Genome Engineering Editing market?
6. What are the growth factors driving the market demand?